Table 1. Timeframe for establishment or reestablishment of capacity to test for key notifiable diseases in Liberia after 2014–2015 Ebola outbreak and response*.
IDSR priority disease | Q1 2016 | Q2 2016 | Q3 2016 | Q4 2016 | Q1 2017 |
---|---|---|---|---|---|
Acute flaccid paralysis | Sent to WHO/regional laboratory outside Liberia for testing | ||||
Acute watery diarrhea (cholera) | † | † | ‡ | § | § |
Acute bloody diarrhea (shigella) | † | † | ‡ | § | § |
Human rabies | Sent to WHO/regional Laboratory outside Liberia for testing | ||||
Lassa fever | † | † | ‡ | § | § |
Measles | ‡ | § | § | § | § |
Meningitis | † | † | † | ‡ | § |
Neonatal tetanus | Not applicable; diagnoses based on clinical symptoms | ||||
Viral hemorrhagic fever (including Ebola virus disease) | § | § | § | § | § |
Yellow fever | ‡ | § | § | § | § |
*IDSR, Integrated Disease Surveillance and Response framework; Q, quarter, WHO, World Health Organization. †Capacity was not available during the specified quarter. ‡Capacity was partially established. §Established laboratory capacity.